Achieve Life Sciences, Inc.

NASDAQ:ACHV

4.71 (USD) • At close November 1, 2024
Bedrijfsnaam Achieve Life Sciences, Inc.
Symbool ACHV
Munteenheid USD
Prijs 4.71
Beurswaarde 161,747,523
Dividendpercentage 0%
52-weken bereik 3.03 - 5.98
Industrie Biotechnology
Sector Healthcare
CEO Mr. John A. Bencich M.B.A.
Website https://www.achievelifesciences.com

An error occurred while fetching data.

Over Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal

Vergelijkbare Aandelen

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.06 USD

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

3.31 USD

BioVie Inc. logo

BioVie Inc.

BIVI

2.77 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

6.01 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.8 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

1.03 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)